Seza Ozen

About Seza Ozen

Seza Ozen, With an exceptional h-index of 105 and a recent h-index of 72 (since 2020), a distinguished researcher at Hacettepe Üniversitesi, specializes in the field of Medicine, Rheumatology, Pediatric Rheumatology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network

Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis

5, 6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or-6 therapy

Treatment with Janus Kinase Inhibitors in Juvenile Dermatomyositis: A Review of the Literature

Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

Acute kidney injury in children with moderate-severe COVID-19 and multisystem inflammatory syndrome in children: a referral center experience

A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry

Seza Ozen Information

University

Position

___

Citations(all)

44839

Citations(since 2020)

21181

Cited By

26355

hIndex(all)

105

hIndex(since 2020)

72

i10Index(all)

431

i10Index(since 2020)

308

Email

University Profile Page

Google Scholar

Seza Ozen Skills & Research Interests

Medicine

Rheumatology

Pediatric Rheumatology

Top articles of Seza Ozen

Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network

Ophthalmology and Therapy

2024/3/30

Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis

2024/3/15

5, 6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

Frontiers in Immunology

2024/3/12

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or-6 therapy

Rheumatology

2024/3/5

Treatment with Janus Kinase Inhibitors in Juvenile Dermatomyositis: A Review of the Literature

2024/3/1

Seza Ozen
Seza Ozen

H-Index: 55

Rhupus syndrome in children: A multi-center retrospective cohort study and literature review

2024/3

Acute kidney injury in children with moderate-severe COVID-19 and multisystem inflammatory syndrome in children: a referral center experience

Pediatric Nephrology

2024/3

A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry

Rheumatology

2024/3/1

Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey

Journal of Clinical Medicine

2024/2/20

Biologic drugs in the treatment of juvenile dermatomyositis: a literature review

2024/2

Seza Ozen
Seza Ozen

H-Index: 55

Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic

2024/1/12

Preferential involvement of the pelvis and hips along with active sacroiliitis in chronic nonbacterial osteomyelitis: MRI of 97 patients from a single tertiary referral center

European Radiology

2024/1/5

The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases

2024/1/5

Seza Ozen
Seza Ozen

H-Index: 55

Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever

Modern Rheumatology

2024/5/1

Seza Ozen
Seza Ozen

H-Index: 55

Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

Pediatric Rheumatology

2024/1/2

A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

2024/5/1

Interleukin-1 Targeted Therapies in Pediatric Rheumatology

2024

Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis

Clinical Rheumatology

2024/4/29

Emil Aliyev
Emil Aliyev

H-Index: 3

Seza Ozen
Seza Ozen

H-Index: 55

Drug-induced lupus erythematosus in childhood: Case-based review

Lupus

2024

Seza Ozen
Seza Ozen

H-Index: 55

See List of Professors in Seza Ozen University(Hacettepe Üniversitesi)